Infor and Tracker Corp Announce Partnership and Deliver

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Infor and Tracker Corp Announce Partnership and Deliver Comprehensive Onboarding Equipped With I-9 and E-Verify Compliance

NEW YORK, NY--(Marketwired - Apr 18, 2013) - Infor , a leading provider of business application software serving more than 70,000 customers, and Tracker Corp , a leading provider of compliance solutions for large organizations, today announced the availability of Infor Onboarding with Tracker I-9 integration, providing a cohesive solution that incorporates I-9 and E-Verify compliance into the onboarding process. Infor Onboarding, which orchestrates the steps involved in the new hire process for employees, hiring managers, line managers and hiring departments, now enhances customers' ability to monitor Form I-9 completion and due dates across all locations and hiring managers directly in Infor Onboarding. This gives the HR function central oversight and control of compliance, enabling higher compliance rates and drastically reduced I-9 overhead.

Part of the Infor HR Service Delivery Suite, Infor Onboarding now can incorporate the completion of Tracker's electronic Form I-9 as a mandatory step in the onboarding process for new hires. Data that was previously collected from the employee is used to prefill the Form I-9 and automatically create an I-9 record in Tracker. Each hiring manager responsible for completing a Form I-9 sees their open actions and next steps at a glance, color coded for time urgency, without ever leaving the Infor Onboarding tour. Email notifications alert responsible parties when due dates get too close.

Also, configurable options based on each client's business process allow users to access I-9 records in Infor Onboarding via single sign-on with Tracker I-9.

"Employers and employees alike want the onboarding process to go as quickly and smoothly as possible, but with multiple moving parts, it's easy to miss something important, or to misplace important documents critical to the new hire process," said Amy Ihlen, industry strategy director, Human Capital Management, Infor. "This new partnership with Tracker I-9 allows us to provide our customers with an automated, flexible solution that will help them reduce time spent on onboarding, reach compliance goals with fewer resources, and avoid costly penalties associated with I-9 errors."

Available on-premise or in the cloud, organizations can simplify I-9 auditing, centralize I-9 management and enforce consistent practices directly through Infor Onboarding.

"With audits increasing and a federal mandate for E-Verify being discussed, large organizations with high volume hiring need a solution for I-9 and E-Verify compliance," said Tim Danison, CEO, Tracker Corp. "This new partnership with Infor provides for more complete and highly efficient onboarding, including enterprise-wide I-9 and E-Verify compliance functionality."

For more information visit http://www.infor.com/product_summary/hcm/hrservicedelivery/ .

About Tracker Corp Tracker Corp is a leading provider of automated I-9 and E-Verify compliance solutions for large organizations with high volume hiring. Its I-9 compliance product, a 2012 SIIA CODie Award finalist for Best Human Capital Solution, increases I-9 compliance while reducing the cost of compliance. Tracker I-9 is used by organizations with thousands of locations and hundreds of thousands of annual hires, including some of the nation's largest retailers, fast casual restaurant chains, grocers, transportation companies, federal contractors, staffing companies and more. Tracker Corp's I-9 remediation product, which automates the process of cleansing historical I-9s, has been used by individual customers to cleanse as many as 500,000 historical I-9s. Tracker Corp customers include The Kroger Co., Limited Brands, Smart & Final, Schneider National, General Mills, and Marathon Petroleum Company. In 2012 Tracker Corp's support organization was awarded a Stevie Award for Front Line Customer Service Center of the Year. To learn more, visit www.trackercorp.com . 

About Infor Infor is one of the world's largest providers of enterprise applications and services, helping 70,000 customers in 194 countries improve operations, drive growth, and quickly adapt to changes in business demands. Infor offers deep industry-specific applications and suites, engineered for speed, using ground-breaking technology that delivers a rich user experience, and flexible deployment options that give customers a choice to run their businesses in the cloud, on-premises, or both. To learn more about Infor, please visit www.infor.com .

This announcement reflects the direction Infor may take with regard to the specific product(s) described herein, all of which is subject to change by Infor in its sole discretion, with or without notice to you. This announcement is not a commitment to you in any way and you should not rely on this document or any of its content in making any decision. Infor is not committing to develop or deliver any specified enhancement, upgrade, product or functionality, even if such is described in this announcement and even if such description is accompanied by words such as "anticipate," "believe," "expect," "intend," "may," "plan," "project," "predict," "should," "will," and/or similar expressions. Many factors can affect Infor's product development plans and the nature, content and timing of future product releases, all of which remain in the sole discretion of Infor. This announcement, in whole or in part, may not be incorporated into any contractual agreement with Infor or its subsidiaries or affiliates. Infor expressly disclaims any liability with respect to this announcement.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading